Gateway Analytical has teamed up with researchers from the Division of Pharmaceutical Analysis at FDA/CDER to present new findings on temperature-mediated agglomeration assessment in Orally Inhaled and Nasal Drug Products. This study was performed to address aqueous nasal spray suspensions stability during long-term shipping/storage. During the study, suspension formulations were subjected to temperatures that may possibly be reached inside shipping containers during hottest and coldest months in St. Louis, MO.
Gateway Analytical Teams up with Researchers from the FDA/CDER/Division of Pharmaceutical Analysis to Present at RDD 2014
[fa icon="calendar'] Feb 13, 2014 3:57:56 PM / by Admin posted in agglomeration assessment, aqueous suspension formulations, Blog, chemically specific, FDA, Nasal Drug Products, Pharmaceutical, Raman chemical imaging